Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1989
05/10/1989EP0172873B1 An erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions
05/10/1989EP0116579B1 Anti wrinkle implant
05/10/1989CN1032816A Monoclonal antibodies against human interleukin-4 and hybridomas producing same
05/10/1989CN1032795A Linear and cyclic analogues of alpha-msh fragments with extraordinary potency
05/10/1989CN1032743A Somatotropin formulations
05/10/1989CN1032741A Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell
05/10/1989CN1032740A Elaboration of host defense mediators into biological fluids by systemic ds rna treatment
05/09/1989USRE32919 Tissue-type plasminogen activator
05/09/1989US4829070 Prodrug for sustained release of dopamine
05/09/1989US4829054 Method of decreasing lung damage in a host following the onset of gram negative septicemia/endotoxemia
05/09/1989US4829053 Renin inhibitors
05/09/1989US4829052 Serine protease inhibitors
05/09/1989US4829051 Controlling bleeding
05/09/1989US4828998 Bacteriolytic enzyme product from streptomyces, a process for its preparation, and a strain suitable for this purpose
05/09/1989US4828995 Fiagnosis and therapy
05/09/1989US4828991 Tumor specific monoclonal antibodies
05/09/1989US4828990 Zinc or copper salt, polyethylenimine
05/09/1989US4828948 Method for the production of heat-resistant structured layers
05/09/1989US4828838 Treatment of human viral infection
05/09/1989US4828830 Method and composition for prophylaxis and treatment of viral infections
05/09/1989US4828821 Glycoprotein, calcium salt crystal growth inhibitor
05/09/1989US4827945 Magnetic resonance imaging
05/09/1989CA1254000A1 Growth hormone releasing factor analogs
05/09/1989CA1253999A1 .alpha.-AMINOBORONIC ACID PEPTIDES
05/09/1989CA1253856A1 Brain-specific drug delivery
05/09/1989CA1253804A1 Cellular viral inhibitor composition
05/09/1989CA1253800A1 Human suppressor factor(s) and method
05/05/1989WO1989003886A1 Expression systems for preparation of polypeptides in prokaryotic cells
05/05/1989WO1989003884A1 Interleukin-7
05/05/1989WO1989003874A1 Novel polypeptide compounds
05/05/1989WO1989003873A1 Regulation of cell proliferation and differentiation using peptides
05/05/1989WO1989003849A1 Oligonucleotide-polyamide conjugates
05/05/1989WO1989003846A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/05/1989WO1989003845A1 Ps2 protein derivative
05/05/1989WO1989003844A1 Hiv peptides, artificial hiv antigens and immunoassay kits
05/05/1989WO1989003843A1 Derivatives of type a and type b synergimycins
05/05/1989WO1989003842A1 Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
05/05/1989WO1989003841A1 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
05/05/1989WO1989003836A1 Factors associated with essential hypertension
05/05/1989WO1989003813A1 Anti-retroviral agent
05/05/1989WO1989003690A1 Application of dinitro-trinitrophenyl and its derivatives or of anti-nitrophenyl antibodies to the modification of the interaction between the target cellules of a host and a pathogenic agent
05/05/1989WO1989003688A1 Amino acid composition for parenteral nutritional support and the use thereof
05/05/1989WO1989003687A1 Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene
05/05/1989WO1989003686A1 Cgrp for cerebral blood supply improvement
05/05/1989WO1989003680A1 Conjugates between a drug and a nitrophenyl group and their pharmaceutical application
05/05/1989WO1989003673A1 Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
05/05/1989WO1989003672A1 Drug comprising the association of polymyxin b, netilmycin and amphotericin b, administered by spraying
05/03/1989EP0314580A1 Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
05/03/1989EP0314576A1 Tetra and pentapeptides with the sequence lysyl-arginyl-aspartyl, and their use as antithrombotics
05/03/1989EP0314534A1 Expression vector for proteins from the HIV-2 virus, one of the agents that cause AIDS
05/03/1989EP0314444A2 Novel oxathiolanes and derivatives thereof, pharmaceutical compositions containing them and the use thereof as medicaments
05/03/1989EP0314421A1 Somatotropin formulations
05/03/1989EP0314415A2 Interleukin-7
05/03/1989EP0314402A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/03/1989EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them
05/03/1989EP0314240A2 Process for purifying recombinant hepatitis antigens
05/03/1989EP0314239A2 Tripeptide renin inhibitors with N-terminal ureido or sulfamido groups
05/03/1989EP0314184A1 Expression plasmids
05/03/1989EP0314095A1 Plasma and recombinant protein formulation in high ionic strength media
05/03/1989EP0314094A2 Recombinant lymphotoxin
05/03/1989EP0314060A2 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
05/03/1989EP0314042A2 Novel copolymers and superoxide dismutase modified with said copolymers
05/03/1989EP0313969A2 Tripeptide derivatives and antiplasmin agents containing the same
05/03/1989EP0313874A2 Disulfur analogs of LL-E33288 antitumor agents
05/03/1989EP0313873A1 Targeted forms of methyltrithio antitumor agents
05/03/1989EP0313697A1 Leukotriene antagonists
05/03/1989EP0313654A1 Drug for prophylaxis and treatment of hepatopathy
05/03/1989EP0313643A1 Methods and compositions for preventing ulcers.
05/03/1989EP0313641A1 Activation antigen
05/03/1989EP0216775B1 Carboxylic acid ester derivatives of deglucoteicoplanin
05/03/1989DE3836006A1 Monophosphoryllipid-a-derivate und verfahren zu deren herstellung Monophosphoryl lipid A derivatives and methods for their preparation
05/02/1989US4826958 Renin inhibiting compounds
05/02/1989US4826855 Thieno pyridines and their use as anti-hypertensive agents
05/02/1989US4826825 Foods, drugs, cosmetics, chemicals, dessication
05/02/1989US4826816 Antihypertensive compounds
05/02/1989US4826815 Renin inhibiting compounds
05/02/1989US4826814 Inhibitors of angiotensin converting enzyme
05/02/1989US4826813 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists
05/02/1989US4826812 Antiglaucoma agent
05/02/1989US4826811 Crosslinked, pyridoxylated hemoglobin free of tetramers
05/02/1989US4826809 Vegetable protein hydrolyzates and mono-, di- or oligosaccharides
05/02/1989US4826763 Genetically transformed saccharomyces
05/02/1989US4826680 Pharmaceutical composition containing thymus extract fractions
05/02/1989US4826679 Composition and methods for alleviating cystic fibrosis
05/02/1989CA1253500A1 Acylaminoalkanoyl urethanes or thiourethanes
04/1989
04/27/1989DE3835099A1 Pharmazeutische zusammensetzung Pharmaceutical composition
04/26/1989EP0313515A1 A polypeptide growth factor from milk
04/26/1989EP0313346A2 Cysteine proteinases, production and use
04/26/1989EP0313224A1 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods
04/26/1989EP0313158A2 Gastrin releasing peptide antagonist
04/26/1989EP0313156A1 SnRNP-A antigen and fragments thereof
04/26/1989EP0313104A2 Purification, production and use of tumor necrosis factors
04/26/1989EP0312942A2 Polypeptides with a prourokinase activity, their production and use
04/26/1989EP0312941A2 Polypeptides with a prourokinase activity, their production and use
04/26/1989EP0312814A1 Dry eye treatment solution
04/26/1989EP0312598A1 Peptide functioning to accelerate activation of protein c with thrombin
04/26/1989CN1032539A Substituted thiophenoimidazole derivatives, process for same, pharmaceutical preparation containing same and use as gastric acid secretive inhibitor
04/25/1989US4824945 Hypocholesterolemically active RNA fractions
04/25/1989US4824938 Stabilized by maltose-containing polysaccharides
04/25/1989US4824937 Synthetic natriuretic peptides
1 ... 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 ... 3163